vs
Side-by-side financial comparison of Protalix BioTherapeutics, Inc. (PLX) and QUICKLOGIC Corp (QUIK). Click either name above to swap in a different company.
Protalix BioTherapeutics, Inc. is the larger business by last-quarter revenue ($9.1M vs $5.7M, roughly 1.6× QUICKLOGIC Corp). QUICKLOGIC Corp runs the higher net margin — -5.4% vs -60.3%, a 55.0% gap on every dollar of revenue. On growth, QUICKLOGIC Corp posted the faster year-over-year revenue change (-24.1% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-1.2M). Over the past eight quarters, QUICKLOGIC Corp's revenue compounded faster (17.2% CAGR vs -6.7%).
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
QuickLogic Corp is a fabless semiconductor company developing low-power customizable FPGAs, embedded FPGA IP, and edge sensor processing solutions. Its offerings serve global wearables, IoT, mobile electronics, and industrial markets, enabling energy-efficient low-latency on-device processing for edge AI and sensing use cases.
PLX vs QUIK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $9.1M | $5.7M |
| Net Profit | $-5.5M | $-305.0K |
| Gross Margin | 49.4% | 62.7% |
| Operating Margin | -51.1% | 2.6% |
| Net Margin | -60.3% | -5.4% |
| Revenue YoY | -49.9% | -24.1% |
| Net Profit YoY | -184.8% | -114.9% |
| EPS (diluted) | $-0.06 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $15.7M | — | ||
| Q1 25 | $10.1M | — | ||
| Q4 24 | $18.2M | $5.7M | ||
| Q3 24 | $18.0M | $4.2M | ||
| Q2 24 | $13.5M | $4.1M | ||
| Q1 24 | — | $5.7M |
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $164.0K | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $6.5M | $-305.0K | ||
| Q3 24 | $3.2M | $-2.1M | ||
| Q2 24 | $-2.2M | $-1.6M | ||
| Q1 24 | — | $108.0K |
| Q4 25 | 49.4% | — | ||
| Q3 25 | 53.4% | — | ||
| Q2 25 | 62.5% | — | ||
| Q1 25 | 19.1% | — | ||
| Q4 24 | 78.7% | 62.7% | ||
| Q3 24 | 53.4% | 59.1% | ||
| Q2 24 | 29.8% | 54.7% | ||
| Q1 24 | — | 67.1% |
| Q4 25 | -51.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | -41.0% | — | ||
| Q4 24 | 39.6% | 2.6% | ||
| Q3 24 | 22.2% | -38.1% | ||
| Q2 24 | -18.0% | -29.3% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | -60.3% | — | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -35.8% | — | ||
| Q4 24 | 35.6% | -5.4% | ||
| Q3 24 | 18.0% | -49.8% | ||
| Q2 24 | -16.4% | -37.8% | ||
| Q1 24 | — | 1.9% |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $0.10 | $-0.02 | ||
| Q3 24 | $0.03 | $-0.14 | ||
| Q2 24 | $-0.03 | $-0.11 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.7M | — |
| Total DebtLower is stronger | — | $3.1M |
| Stockholders' EquityBook value | $48.2M | $24.9M |
| Total Assets | $82.3M | $51.9M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.7M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $17.9M | — | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $27.4M | — | ||
| Q2 24 | $23.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $1.4M |
| Q4 25 | $48.2M | — | ||
| Q3 25 | $52.9M | — | ||
| Q2 25 | $49.9M | — | ||
| Q1 25 | $45.2M | — | ||
| Q4 24 | $43.2M | $24.9M | ||
| Q3 24 | $32.4M | $20.9M | ||
| Q2 24 | $28.6M | $21.8M | ||
| Q1 24 | — | $22.2M |
| Q4 25 | $82.3M | — | ||
| Q3 25 | $82.3M | — | ||
| Q2 25 | $78.5M | — | ||
| Q1 25 | $73.9M | — | ||
| Q4 24 | $73.4M | $51.9M | ||
| Q3 24 | $61.6M | $49.7M | ||
| Q2 24 | $91.5M | $47.5M | ||
| Q1 24 | — | $51.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.12× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | 0.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.0M | $116.0K |
| Free Cash FlowOCF − Capex | $1.6M | $-1.2M |
| FCF MarginFCF / Revenue | 17.8% | -20.6% |
| Capex IntensityCapex / Revenue | 4.4% | 22.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.6M | $-5.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-3.7M | — | ||
| Q2 25 | $-5.2M | — | ||
| Q1 25 | $-5.1M | — | ||
| Q4 24 | $4.0M | $116.0K | ||
| Q3 24 | $4.1M | $-16.0K | ||
| Q2 24 | $-3.6M | $-220.0K | ||
| Q1 24 | — | $147.0K |
| Q4 25 | $1.6M | — | ||
| Q3 25 | $-4.2M | — | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $3.6M | $-1.2M | ||
| Q3 24 | $4.0M | $-83.0K | ||
| Q2 24 | $-3.8M | $-4.2M | ||
| Q1 24 | — | $62.0K |
| Q4 25 | 17.8% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -36.2% | — | ||
| Q1 25 | -53.0% | — | ||
| Q4 24 | 19.6% | -20.6% | ||
| Q3 24 | 22.4% | -2.0% | ||
| Q2 24 | -28.1% | -102.2% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | 4.4% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 2.3% | 22.6% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 1.3% | 96.9% | ||
| Q1 24 | — | 1.5% |
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
QUIK
| North America | $3.0M | 53% |
| Other | $2.7M | 47% |
